Clinical trial
Predictors and Outcomes of Meropenem Treatment Failure Among Patients With Septic Shock in Intensive Care Unit
NCT04042662 is registered in ClinicalTrials.gov with Universiti Sains Malaysia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictors and Outcomes of Meropenem Treatment Failure Among Patients With Septic Shock in Intensive Care Unit
- Lead sponsor
- Universiti Sains Malaysia
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 5, 2019
- Completion date
- August 5, 2020
- Enrollment
- 400 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
predictors and outcomes of meropenem treatment failure